166 related articles for article (PubMed ID: 15316323)
1. Expression of alpha-methylacyl-coenzyme A racemase in nephrogenic adenoma.
Gupta A; Wang HL; Policarpio-Nicolas ML; Tretiakova MS; Papavero V; Pins MR; Jiang Z; Humphrey PA; Cheng L; Yang XJ
Am J Surg Pathol; 2004 Sep; 28(9):1224-9. PubMed ID: 15316323
[TBL] [Abstract][Full Text] [Related]
2. Expression of alpha-methylacyl-CoA racemase (P504S) in nephrogenic adenoma: a significant immunohistochemical pitfall compounding the differential diagnosis with prostatic adenocarcinoma.
Skinnider BF; Oliva E; Young RH; Amin MB
Am J Surg Pathol; 2004 Jun; 28(6):701-5. PubMed ID: 15166661
[TBL] [Abstract][Full Text] [Related]
3. S-100A1 is a reliable marker in distinguishing nephrogenic adenoma from prostatic adenocarcinoma.
Cossu-Rocca P; Contini M; Brunelli M; Festa A; Pili F; Gobbo S; Eccher A; Mura A; Massarelli G; Martignoni G
Am J Surg Pathol; 2009 Jul; 33(7):1031-6. PubMed ID: 19384190
[TBL] [Abstract][Full Text] [Related]
4. Nephrogenic adenoma of the prostatic urethra: a mimicker of prostate adenocarcinoma.
Allan CH; Epstein JI
Am J Surg Pathol; 2001 Jun; 25(6):802-8. PubMed ID: 11395559
[TBL] [Abstract][Full Text] [Related]
5. Nephrogenic adenoma: immunohistochemical evaluation for its etiology and differentiation from prostatic adenocarcinoma.
Xiao GQ; Burstein DE; Miller LK; Unger PD
Arch Pathol Lab Med; 2006 Jun; 130(6):805-10. PubMed ID: 16740031
[TBL] [Abstract][Full Text] [Related]
6. Nephrogenic adenoma: an immunohistochemical analysis using biotin-free methods.
Ortiz-Rey JA; Antón-Badiola I; Pérez-Pedrosa A; Peteiro-Cancelo Á; González-Carreró J
Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):386-91. PubMed ID: 22495376
[TBL] [Abstract][Full Text] [Related]
7. Revisiting the immunophenotype of nephrogenic adenoma.
Fromont G; Barcat L; Gaudin J; Irani J
Am J Surg Pathol; 2009 Nov; 33(11):1654-8. PubMed ID: 19730362
[TBL] [Abstract][Full Text] [Related]
8. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
Sung MT; Jiang Z; Montironi R; MacLennan GT; Mazzucchelli R; Cheng L
Hum Pathol; 2007 Feb; 38(2):332-41. PubMed ID: 17134736
[TBL] [Abstract][Full Text] [Related]
9. Detection of alpha-methylacyl-coenzyme A racemase in postradiation prostatic adenocarcinoma.
Yang XJ; Laven B; Tretiakova M; Blute RD; Woda BA; Steinberg GD; Jiang Z
Urology; 2003 Aug; 62(2):282-6. PubMed ID: 12893336
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical staining characteristics of nephrogenic adenoma using the PIN-4 cocktail (p63, AMACR, and CK903) and GATA-3.
McDaniel AS; Chinnaiyan AM; Siddiqui J; McKenney JK; Mehra R
Am J Surg Pathol; 2014 Dec; 38(12):1664-71. PubMed ID: 24921643
[TBL] [Abstract][Full Text] [Related]
11. 34BetaE12 and Alfa-Methylacyl Coenzyme A Racemase (AMACR) Antibodies Better Than p63 Antibody Distinguish Normal and Neoplastic Glands in Prostatic Tissue With Thermal Artifacts.
Pierconti F; Rossi ED; Martini M; Sacco E; Bassi PF; Larocca LM
Appl Immunohistochem Mol Morphol; 2019 Apr; 27(4):306-310. PubMed ID: 29346181
[TBL] [Abstract][Full Text] [Related]
12. Reliability of the 34βE12, keratin 5/6, p63, bcl-2, and AMACR in the diagnosis of prostate carcinoma.
Boran C; Kandirali E; Yilmaz F; Serin E; Akyol M
Urol Oncol; 2011; 29(6):614-23. PubMed ID: 20189848
[TBL] [Abstract][Full Text] [Related]
13. [Pathological and immunohistochemical analyses of 32 cases of nephrogenic adenoma].
Shen Q; Sun LH; Wang JH; Liu LB; He Q; Jin J
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Aug; 45(4):522-6. PubMed ID: 23939154
[TBL] [Abstract][Full Text] [Related]
14. Fibromyxoid nephrogenic adenoma: a newly recognized variant mimicking mucinous adenocarcinoma.
Hansel DE; Nadasdy T; Epstein JI
Am J Surg Pathol; 2007 Aug; 31(8):1231-7. PubMed ID: 17667548
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of alpha-methylacyl-coenzyme A racemase in prostatic adenocarcinoma following hormone therapy.
Suzue K; Montag AG; Tretiakova M; Yang XJ; Sahoo S
Am J Clin Pathol; 2005 Apr; 123(4):553-61. PubMed ID: 15743746
[TBL] [Abstract][Full Text] [Related]
16. Alpha-methylacyl coenzyme A racemase immunoreactivity in partial atrophy of the prostate.
Adley BP; Yang XJ
Am J Clin Pathol; 2006 Dec; 126(6):849-55. PubMed ID: 17074684
[TBL] [Abstract][Full Text] [Related]
17. Flat pattern of nephrogenic adenoma: previously unrecognized pattern unveiled using PAX2 and PAX8 immunohistochemistry.
Piña-Oviedo S; Shen SS; Truong LD; Ayala AG; Ro JY
Mod Pathol; 2013 Jun; 26(6):792-8. PubMed ID: 23328975
[TBL] [Abstract][Full Text] [Related]
18. Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens.
Jiang Z; Li C; Fischer A; Dresser K; Woda BA
Am J Clin Pathol; 2005 Feb; 123(2):231-6. PubMed ID: 15842047
[TBL] [Abstract][Full Text] [Related]
19. Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer.
Zhou M; Jiang Z; Epstein JI
Am J Surg Pathol; 2003 Jun; 27(6):772-8. PubMed ID: 12766580
[TBL] [Abstract][Full Text] [Related]
20. Age-associated changes in alpha-methyl CoA racemase (AMACR) expression in nonneoplastic prostatic tissues.
Gologan A; Bastacky S; McHale T; Yu J; Cai C; Monzon-Bordonaba F; Dhir R
Am J Surg Pathol; 2005 Nov; 29(11):1435-41. PubMed ID: 16224209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]